z-logo
open-access-imgOpen Access
Targeted Nanobubbles of PD-L1 mAb Combined with Doxorubicin as a Synergistic Tumor Repressor in Hepatocarcinoma
Author(s) -
Yezi Chen,
Xiaoqin Luo,
Yun Liu,
Yunlei Zou,
Shiqi Yang,
Chaoqi Liu,
Yun Zhao
Publication year - 2022
Publication title -
international journal of nanomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.245
H-Index - 128
eISSN - 1178-2013
pISSN - 1176-9114
DOI - 10.2147/ijn.s376172
Subject(s) - doxorubicin , in vivo , monoclonal antibody , cancer research , immunotherapy , in vitro , biotinylation , apoptosis , chemistry , medicine , chemotherapy , immune system , antibody , biology , immunology , biochemistry , microbiology and biotechnology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here